Contrast-Enhanced Ultrasound in Human Crohn's Disease

Withdrawn before enrolling · Phase 1/Phase 2

Conditions studied: Crohn's Disease

In brief

To determine if contrast enhanced ultrasound (CEUS) and shear wave elastography can accurately diagnose bowel wall inflammation and fibrosis in patients with known Crohn's disease.

Key facts

Study ID

NCT02061163

Run by

University of Michigan

People needed

0

Starts

2015-02-01

Expected to finish

2018-01-01

Last updated by the study team

2015-06-15

Who can join

Age: 10 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients 10 years of age and older
• Have been diagnosed with small bowel Crohn's disease
• Are receiving medical therapy for Crohn's disease
• Are scheduled for surgery (bowel resection) OR
• Are scheduled for a clinically-indicated MR enterography (MRE)/MRI exam.

You may not qualify if…

• Patients under the age of 10
• Are pregnant or breast feeding
• Are significantly overweight - BMI >35-40
• Have an inability to understand the consent
• Have prior allergic-like reaction or other adverse reaction to microbubble contrast agent
• Hypersensitivity to perflutren, blood, blood products or albumen
• Have a cardiac shunt
• Known unstable cardiac condition such as history of a heart attach, irregular heartbeat, congestive heart failure, etc.
• Known acute or chronic kidney disease, moderate/severe lung disease or acute or chronic liver disease

Where it is running

• University of Michigan C.S. Mott Children's Hospital — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.